Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases

Background. Histoplasmosis may complicate tumor necrosis factor (TNF)–α blocker therapy. Published case series provide limited guidance on disease management. We sought to determine the need for long-term antifungal therapy and the safety of resuming TNF-α blocker therapy after successful treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Infect Dis
Asıl Yazarlar: Vergidis, Paschalis, Avery, Robin K., Wheat, L. Joseph, Dotson, Jennifer L., Assi, Maha A., Antoun, Smyrna A., Hamoud, Kassem A., Burdette, Steven D., Freifeld, Alison G., McKinsey, David S., Money, Mary E., Myint, Thein, Andes, David R., Hoey, Cynthia A., Kaul, Daniel A., Dickter, Jana K., Liebers, David E., Miller, Rachel A., Muth, William E., Prakash, Vidhya, Steiner, Frederick T., Walker, Randall C., Hage, Chadi A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2015
Konular:
Articles and Commentaries
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4796723/
https://ncbi.nlm.nih.gov/pubmed/25870331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ299
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller